SCHEMBL11568552

SCHEMBL11568552

COC(=O)/C=C(/C)Nc1ccc(OC)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.66
RAB9A P51151 9/20 0.66
MAPT P10636 8/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
ALDH1A1 P00352 3/20 0.62
TDP1 Q9NUW8 1/20 0.59
TGM2 P21980 1/20 0.56
PTGS2 P35354 1/20 0.56
TP53 P04637 2/20 0.54
ALOX15 P16050 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11345591 0.91 MAPT (0.53) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL19379963 0.86 RAB9A (0.70) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18587028 0.86 RAB9A (0.70) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18587029 0.86 RAB9A (0.70) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL10862976 0.86 MAPT (0.58) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL10558301 0.86 MAPT (0.58) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL10558287 0.86 MAPT (0.58) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL3737335 0.86 MAPT (0.60) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL3737334 0.86 MAPT (0.60) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL13628941 0.86 MAPT (0.60) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0002231-A1 1-N-aryl-1,4-dihydropyridines, process for their preparation and their pharmaceutical application BAYER AG (DE) 1979-06-13 EP disclosed